Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance

• Status: Completed
• Trial end date: 2019-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventing MRSA infections in the large group of high risk MRSA-positive patients being discharged from hospitals. Findings could potentially impact best practice for the 1.8 million MRSA carriers who are discharged from US hospitals each year.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, Irvine
• Collaborator: Agency for Healthcare Research and Quality (AHRQ)
• Treatments: Anti-Bacterial Agents

Criteria

Inclusion Criteria:

• 1) At least 18 years old

• 2) Have had a positive culture (a type of test) for MRSA during recent hospital admission or within the 30 days prior to admission or following discharge

• 3) Able to give consent or have a primary caregiver provide consent

• 4) Able to bathe or shower or have this consistently performed by a willing caregiver

Exclusion Criteria:

• 1) Known allergies to chlorhexidine or mupirocin